FinTrust Capital Advisors’s Elevance Health ELV Stock Holding History

FinTrust Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$33.3K	Buy	64 +2	+3%	+$1.07K	0.01%	696
2024 Q2	$33.6K	Buy	62 +20	+48%	+$10.6K	0.01%	651
2024 Q1	$21.8K	Buy	42 +2	+5%	+$995	﹤0.01%	715
2023 Q4	$18.9K	Hold	40	–	–	﹤0.01%	706
2023 Q3	$17.4K	Buy	40 +5	+14%	+$2.27K	﹤0.01%	686
2023 Q2	$18K	Hold	35	–	–	﹤0.01%	673
2023 Q1	$18K	Hold	35	–	–	﹤0.01%	671
2022 Q4	$18K	Hold	35	–	–	﹤0.01%	668
2022 Q3	$17K	Buy	35 +8	+30%	+$3.83K	﹤0.01%	754
2022 Q2	$12K	Sell	27 -12	-31%	-$5.94K	﹤0.01%	836
2022 Q1	$19K	Hold	39	–	–	﹤0.01%	774
2021 Q4	$18K	Buy	+39	New	+$16.4K	﹤0.01%	767
2020 Q3	–	Sell	-60	Closed	-$16K	–	1154
2020 Q2	$16K	Sell	60 -125	-68%	-$33.3K	0.01%	662
2020 Q1	$42K	Sell	185 -64	-26%	-$17.4K	0.02%	472
2019 Q4	$75K	Buy	249 +14	+6%	+$3.85K	0.03%	369
2019 Q3	$56K	Sell	235 -16	-6%	-$4.38K	0.02%	425
2019 Q2	$71K	Buy	251 +81	+48%	+$22.1K	0.03%	341
2019 Q1	$49K	Buy	170 +62	+57%	+$17.9K	0.02%	397
2018 Q4	$28K	Buy	+108	New	+$29.7K	0.01%	507

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

FinTrust Capital Advisors's ELV Position: Q3 2024 in Review

FinTrust Capital Advisors increased its Elevance Health (ELV) stake by 3.2% in Q3 2024, buying an estimated $1.07K and bringing the position to 64 shares worth $33.3K. The position accounts for 0.01% of the portfolio, ranked #696.

FinTrust Capital Advisors first reported a position in ELV in Q4 2018 and has held it in 19 quarters since. The position peaked at $75K in Q4 2019. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

FinTrust Capital Advisors held 64 shares of Elevance Health worth $33.3K as of Q3 2024.
FinTrust Capital Advisors bought 2 Elevance Health shares in Q3 2024, an estimated $1.07K.
Elevance Health made up 0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #696 holding.
FinTrust Capital Advisors first reported a position in Elevance Health in Q4 2018 and has held it in 19 quarters since.
FinTrust Capital Advisors's Elevance Health position peaked at $75K in Q4 2019.
1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.